Logo image of GRO

BRAZIL POTASH CORP (GRO) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:GRO - CA10586A1084 - Common Stock

2.285 USD
-0.04 (-1.93%)
Last: 1/13/2026, 8:04:00 PM
2.2405 USD
-0.04 (-1.95%)
After Hours: 1/13/2026, 8:04:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GRO. GRO was compared to 82 industry peers in the Chemicals industry. While GRO seems to be doing ok healthwise, there are quite some concerns on its profitability. GRO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • GRO had negative earnings in the past year.
  • GRO had a negative operating cash flow in the past year.
GRO Yearly Net Income VS EBIT VS OCF VS FCFGRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

  • GRO's Return On Assets of -45.79% is on the low side compared to the rest of the industry. GRO is outperformed by 93.90% of its industry peers.
  • With a Return On Equity value of -47.76%, GRO is not doing good in the industry: 81.71% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -45.79%
ROE -47.76%
ROIC N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRO Yearly ROA, ROE, ROICGRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

  • GRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GRO Yearly Profit, Operating, Gross MarginsGRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

  • GRO has less shares outstanding than it did 1 year ago.
  • GRO has a worse debt/assets ratio than last year.
GRO Yearly Shares OutstandingGRO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GRO Yearly Total Debt VS Total AssetsGRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M

2.2 Solvency

  • GRO has an Altman-Z score of 9.99. This indicates that GRO is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 9.99, GRO belongs to the best of the industry, outperforming 98.78% of the companies in the same industry.
  • GRO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With an excellent Debt to Equity ratio value of 0.00, GRO belongs to the best of the industry, outperforming 96.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.99
ROIC/WACCN/A
WACCN/A
GRO Yearly LT Debt VS Equity VS FCFGRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 3.09 indicates that GRO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.09, GRO belongs to the top of the industry, outperforming 84.15% of the companies in the same industry.
  • GRO has a Quick Ratio of 3.09. This indicates that GRO is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.09, GRO belongs to the best of the industry, outperforming 91.46% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 3.09
GRO Yearly Current Assets VS Current LiabilitesGRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

  • GRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -294.90%.
EPS 1Y (TTM)-294.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.51%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, GRO will show a very strong growth in Earnings Per Share. The EPS will grow by 26.90% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-19.48%
EPS Next 2Y26.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRO Yearly EPS VS EstimatesGRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • GRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year GRO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRO Price Earnings VS Forward Price EarningsGRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRO Per share dataGRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as GRO's earnings are expected to grow with 26.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.9%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for GRO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

BRAZIL POTASH CORP

NYSEARCA:GRO (1/13/2026, 8:04:00 PM)

After market: 2.2405 -0.04 (-1.95%)

2.285

-0.04 (-1.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners2.58%
Inst Owner Change0%
Ins Owners4.95%
Ins Owner ChangeN/A
Market Cap121.79M
Revenue(TTM)N/A
Net Income(TTM)-66.88M
Analysts80
Price Target3.32 (45.3%)
Short Float %0.25%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-438.37%
Min EPS beat(2)-494.06%
Max EPS beat(2)-382.67%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-13.33%
PT rev (3m)-13.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.87
P/tB 0.87
EV/EBITDA N/A
EPS(TTM)-2.11
EYN/A
EPS(NY)-0.3
Fwd EYN/A
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0
BVpS2.63
TBVpS2.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -45.79%
ROE -47.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 3.09
Altman-Z 9.99
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.51%
EPS Next Y-19.48%
EPS Next 2Y26.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-249.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-40.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.56%
OCF growth 3YN/A
OCF growth 5YN/A

BRAZIL POTASH CORP / GRO FAQ

Can you provide the ChartMill fundamental rating for BRAZIL POTASH CORP?

ChartMill assigns a fundamental rating of 2 / 10 to GRO.


What is the valuation status of BRAZIL POTASH CORP (GRO) stock?

ChartMill assigns a valuation rating of 1 / 10 to BRAZIL POTASH CORP (GRO). This can be considered as Overvalued.


What is the profitability of GRO stock?

BRAZIL POTASH CORP (GRO) has a profitability rating of 0 / 10.


What is the financial health of BRAZIL POTASH CORP (GRO) stock?

The financial health rating of BRAZIL POTASH CORP (GRO) is 6 / 10.